RHÖN-KLINIKUM AG / Key word(s): Quarter Results08.11.2012 / 07:03
 RHÖN-KLINIKUM AG reports +11.6 % growth in patient numbers Revenues increase by +8.4 % to reach EUR 2.12 billion Key personnel changes completed, focus on strategic conceptBad Neustadt a. d. Saale, 8 November 2012Patient numbers and revenues at the Group of RHÖN-KLINIKUM AG have steadilyincreased in the first three quarters of 2012. In the first nine months,1,899,013 patients were treated, 11.6 per cent more than over the sameperiod of the previous year. Revenues climbed by 8.4 per cent to reach EUR2.12 billion. The pleasing organic growth in revenues was further helped bythe consolidation of Dr. Horst Schmidt Kliniken (HSK) in Wiesbaden.During the reporting period, net consolidated profit stood at EUR 70.2million, and was thus -41.6 per cent below the level of the same period in2011. Operating EBITDA declined over the same period by -11.7 per cent toEUR 215.3 million. These developments in the first nine months of the yearhave come in the wake of the takeover offer by Fresenius, regulatory andwage burdens as well as delays in major restructuring projects. Thepre-year figures were moreover positively influenced by one-off,non-operative extraordinary effects. EBIT declined in the first threequarters of 2012 by -27.2 per cent to EUR 111.4 million.After deducting minority interests in profit of EUR 1.9 million from netconsolidated profit of the first nine months, earnings per share (EPS)stands at EUR 0.49.The situation at Gießen and Marburg University Hospital (UKGM) has furtherintensified over the past months with the result that the outlook in thisarea for 2012 has to be revised downwards by roughly EUR 15 million, as theCompany already informed yesterday. After re-assessing the situation atUKGM, and with the backing of a consensus-based restructuring plan preparedby a renowned corporate consultancy firm, the Board of Management of theCompany is now convinced that the prospects for the successful business andmanagement restructuring of the university hospital are promising.At the level of the Group as a whole, additional burdens in thesingle-digit million range have arisen in the second half of the year, withthe result that these, coupled with the burdens from UKGM, will feedthrough to full-year operating earnings (EBITDA) to the tune of roughly EUR20 million. For financial year 2012, RHÖN-KLINIKUM AG thus expects revenuesof EUR 2.85 billion, which may fluctuate within a range of plus or minus2.5 per cent. This revenue target is accompanied by a forecast for EBITDAof EUR 295 million and for net consolidated profit of EUR 95 million, ineach case subject to a variation of +/- 5 per cent.'Operating efficiency and economic viability are the very basis for thesuccess of RHÖN-KLINIKUM AG - the basis for continuing this success storyhas been provided', said Wolfgang Pföhler, chairman of the Board ofManagement of RHÖN-KLINIKUM AG. 'Rising patient numbers and revenues havealso been achieved thanks to our steadfast efforts at reviewing andoptimising our processes and strategies. The Company's long-term objectiveof establishing a care offering at the national level continues to be thefocus of our efforts. The Company will continue to work towards thisobjective with various strategy projects'.OutlookThe German legislator has taken various measures and provisions introducinga new financing basis for the hospital area. The additional financing dueto the high collective wage deals will benefit hospitals already this year,albeit only partially and, on the whole, inadequately. The introduction ofa pro rated orientation value for rising prices from 2013 is an importantstep towards greater transparency in the actual cost trend at thehospitals. Nonetheless, the orientation value published in September 2012for the first time, at 2 per cent, represents only a small price rise forhospitals.Yesterday's decision by the Supervisory Board of RHÖN-KLINIKUM AG toappoint Dr. med. Dr. jur. Martin Siebert as the future chairman of theBoard of Management brings the round of key personnel decision of recentweeks to a conclusion, with the result that the Company can now press aheadfurther with strategic work on realising an innovative, national careoffering as announced in early October and now begun under the lead of theBoard of Management.End of Corporate News
08.11.2012 Dissemination of a Corporate News, transmitted by DGAP - acompany of EquityStory AG.The issuer is solely responsible for the content of this announcement.DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service 
 192126 08.11.2012